How much is the latest price of Venetoclax in 2024?
Venetoclax is an oral targeted drug used to treat certain types of blood cancers. Its main mechanism of action is by inhibiting the function of the BCL-2 (BCL-2) protein. BCL-2 is an anti-apoptotic protein highly expressed in cancer cells, which can help cancer cells escape the natural apoptosis process. By inhibiting BCL-2, venetoclax prompts cancer cells to undergo apoptosis, thereby reducing the number of malignant cells.
Venetoclax is currently on the market in China and has been included in medical insurance. Patients can purchase it domestically. 100mg*28 tablets are priced at about 2,000 yuan. Please consult the local hospital pharmacy for specific prices and medical insurance reimbursement policies. The cheaper ones abroad are generic drugs, and the cheaper ones are generic drugs from Laos and Bangladesh. 100mg*120The price of 100mg*120 tablets is about more than 2,000 yuan, and there are also small sizes that cost several hundred yuan, which is much cheaper than domestic drugs, and the drug ingredients are basically the same as the domestically imported original drugs.

Venetoclax is commonly used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), especially in patients who have failed other treatments or whose disease has recurred. It is also used to treat acute myeloid leukemia (AML), especially in elderly patients who cannot tolerate traditional chemotherapy, and is often used in combination with other drugs to improve efficacy.
The use of venetoclax requires a gradual increase in dose to reduce the potential risk of tumor lysis syndrome, a life-threatening complication caused by the rapid rupture of cancer cells releasing their contents. Common side effects include neutropenia, anemia, fatigue, nausea, and infection.
Due to its high selectivity for specific proteins, venetoclax is of great significance in the field of precision medicine, but its use requires strict monitoring of blood images and related indicators under the guidance of a doctor to avoid serious adverse reactions.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)